Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia.

Lee HJ, Muindi JR, Tan W, Hu Q, Wang D, Liu S, Wilding GE, Ford LA, Sait SN, Block AW, Adjei AA, Barcos M, Griffiths EA, Thompson JE, Wang ES, Johnson CS, Trump DL, Wetzler M.

Cancer. 2014 Feb 15;120(4):521-9. doi: 10.1002/cncr.28368. Epub 2013 Oct 25.

2.

Activation of tongue-expressed GPR40 and GPR120 by non caloric agonists is not sufficient to drive preference in mice.

Godinot N, Yasumatsu K, Barcos ME, Pineau N, Ledda M, Viton F, Ninomiya Y, le Coutre J, Damak S.

Neuroscience. 2013 Oct 10;250:20-30. doi: 10.1016/j.neuroscience.2013.06.043. Epub 2013 Jul 4.

PMID:
23831422
3.

Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.

Al Ustwani O, Ford LA, Sait SJ, Block AM, Barcos M, Vigil CE, Griffiths EA, Thompson JE, Wang ES, Ambrus J Jr, Wetzler M.

Leuk Res. 2013 Aug;37(8):894-9. doi: 10.1016/j.leukres.2013.04.007. Epub 2013 May 18. Review.

4.

Is obesity a prognostic factor for acute myeloid leukemia outcome?

Lee HJ, Licht AS, Hyland AJ, Ford LA, Sait SN, Block AW, Barcos M, Baer MR, Wang ES, Wetzler M.

Ann Hematol. 2012 Mar;91(3):359-65. doi: 10.1007/s00277-011-1319-8. Epub 2011 Sep 21.

5.

Smoking adversely affects survival in acute myeloid leukemia patients.

Varadarajan R, Licht AS, Hyland AJ, Ford LA, Sait SN, Block AW, Barcos M, Baer MR, Wang ES, Wetzler M.

Int J Cancer. 2012 Mar 15;130(6):1451-8. doi: 10.1002/ijc.26151. Epub 2011 Aug 2.

6.

Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia.

Wetzler M, Andrews C, Ford LA, Tighe S, Barcos M, Sait SN, Block AW, Nowak NJ, Baer MR, Wang ES, Baumann H.

Cancer. 2011 Nov 1;117(21):4861-8. doi: 10.1002/cncr.26097. Epub 2011 Mar 31.

7.

[Partial trisomy and mosaicism associated with Fallot Tetralogy].

Tejero Hernández MA, Gómez Guzmán E, Espejo Portero I, Barcos M.

An Pediatr (Barc). 2011 Jan;74(1):55-6. doi: 10.1016/j.anpedi.2010.08.004. Epub 2010 Dec 10. Spanish. No abstract available.

8.

Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 cases.

Noor SJ, Tan W, Wilding GE, Ford LA, Barcos M, Sait SN, Block AW, Thompson JE, Wang ES, Wetzler M.

Leuk Res. 2011 May;35(5):608-13. doi: 10.1016/j.leukres.2010.07.031. Epub 2010 Aug 19. Review.

9.

Long-term safety and efficacy of cyclosporin A therapy for T-cell large granular lymphocyte leukemia.

Pawarode A, Wallace PK, Ford LA, Barcos M, Baer MR.

Leuk Lymphoma. 2010 Feb;51(2):338-41. doi: 10.3109/10428190903470851. No abstract available.

PMID:
20038217
10.

Inhibition of nitric oxide synthesis during induced cholestasis ameliorates hepatocellular injury by facilitating S-nitrosothiol homeostasis.

López-Sánchez LM, Corrales FJ, Barcos M, Espejo I, Muñoz-Castañeda JR, Rodríguez-Ariza A.

Lab Invest. 2010 Jan;90(1):116-27. doi: 10.1038/labinvest.2009.104. Epub 2009 Oct 5.

11.

Detection of extra-medullary relapse of acute lymphoblastic leukemia by radiographic imaging following allogeneic hematopoietic SCT.

Francis J, Smiley S, Battiwalla M, Wetzler M, Barcos M, Bshara W, Paplham P, Brown K, Syta M, Lamonica D, Loud P, McCarthy P.

Bone Marrow Transplant. 2009 Dec;44(12):827-8. doi: 10.1038/bmt.2009.183. Epub 2009 Jul 27. No abstract available.

PMID:
19633688
12.

Alteration of the renal regulatory hormonal pattern during experimental obstructive jaundice.

Padillo FJ, Cruz A, Espejo I, Barcos M, Gómez-Alvarez M, Muntané J.

Rev Esp Enferm Dig. 2009 Jun;101(6):408-12.

13.

Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial.

Chanan-Khan A, Miller KC, Musial L, Padmanabhan S, Yu J, Ailawadhi S, Sher T, Mohr A, Bernstein ZP, Barcos M, Patel M, Iancu D, Lee K, Czuczman MS.

Leuk Lymphoma. 2009 Jul;50(7):1096-101. doi: 10.1080/10428190902912460.

PMID:
19479618
14.

Treating octogenarian and nonagenarian acute myeloid leukemia patients--predictive prognostic models.

Harb AJ, Tan W, Wilding GE, Ford L, Sait SN, Block AW, Barcos M, Wallace PK, Wang ES, Wetzler M.

Cancer. 2009 Jun 1;115(11):2472-81. doi: 10.1002/cncr.24285.

15.

Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer.

Varadarajan R, Ford L, Sait SN, Block AW, Barcos M, Wallace PK, Ramnath N, Wang ES, Wetzler M.

Leuk Res. 2009 Sep;33(9):1208-11. doi: 10.1016/j.leukres.2008.12.016. Epub 2009 Jan 31.

16.

Melatonin exerts a more potent effect than S-adenosyl-l-methionine against iron metabolism disturbances, oxidative stress and tissue injury induced by obstructive jaundice in rats.

Muñoz-Castañeda JR, Túnez I, Herencia C, Ranchal I, González R, Ramírez LM, Arjona A, Barcos M, Espejo I, Cruz A, Montilla P, Padillo FJ, Muntané J.

Chem Biol Interact. 2008 Jul 30;174(2):79-87. doi: 10.1016/j.cbi.2008.05.016. Epub 2008 May 18.

PMID:
18571630
17.

Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.

Simpson-Abelson MR, Sonnenberg GF, Takita H, Yokota SJ, Conway TF Jr, Kelleher RJ Jr, Shultz LD, Barcos M, Bankert RB.

J Immunol. 2008 May 15;180(10):7009-18.

18.

Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.

Ramkumar B, Chadha MK, Barcos M, Sait SN, Heyman MR, Baer MR.

Cancer Genet Cytogenet. 2008 Apr 15;182(2):126-9. doi: 10.1016/j.cancergencyto.2008.01.004. Erratum in: Cancer Genet Cytogenet. 2008 Oct 15;186(2):130.

PMID:
18406875
19.

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.

Arana-Yi C, Block AW, Sait SN, Ford LA, Barcos M, Baer MR.

Leuk Res. 2008 Jul;32(7):1043-8. Epub 2008 Feb 21.

PMID:
18093651
20.

Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.

Sait SN, Claydon MA, Conroy JM, Nowak NJ, Barcos M, Baer MR.

Cancer Genet Cytogenet. 2007 Sep;177(2):143-6.

PMID:
17854671
21.

Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case.

Zeidan A, Kakati S, Anderson B, Barcos M, Wetzler M.

Cancer Genet Cytogenet. 2007 Jul 15;176(2):169-71. No abstract available.

22.

Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.

Abdelhalim A, Barcos M, Block AW, Sait SN, Starostik P, Wetzler M, Wang ES.

Leuk Lymphoma. 2007 May;48(5):1053-6. No abstract available.

PMID:
17487757
23.

High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.

Peterson BA, Johnson J, Shipp MA, Barcos M, Gockerman JP, Canellos GP; Cancer and Leukemia Group B 9351.

Leuk Lymphoma. 2007 May;48(5):870-80.

PMID:
17487729
24.

Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.

Pawarode A, Sait SN, Nganga A, Coignet LJ, Barcos M, Baer MR.

Leuk Res. 2007 Nov;31(11):1589-92. Epub 2007 Mar 27.

PMID:
17391756
25.

Routine immunophenotyping in acute leukemia: Role in lineage assignment and reassignment.

Qadir M, Barcos M, Stewart CC, Sait SN, Ford LA, Baer MR.

Cytometry B Clin Cytom. 2006 Sep 15;70(5):329-34.

26.

Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia.

Pawarode A, Finlay E, Sait SN, Barcos M, Baer MR.

Cancer Genet Cytogenet. 2006 Jun;167(2):155-60.

PMID:
16737916
27.

Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature.

Pawarode A, Baer MR, Padmanabhan S, Wallace PK, Barcos M, Sait SN, Block AW, Wetzler M, Battiwalla M.

Leuk Lymphoma. 2005 Dec;46(12):1813-8. Review.

PMID:
16263586
28.

Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats.

Montilla P, Barcos M, Munoz MC, Bujalance I, Munoz-Castaneda JR, Tunez I.

J Biochem Mol Biol. 2005 Sep 30;38(5):539-44.

PMID:
16202232
29.

Genomic profiling of myeloid sarcoma by array comparative genomic hybridization.

Deeb G, Baer MR, Gaile DP, Sait SN, Barcos M, Wetzler M, Conroy JM, Nowak NJ, Cowell JK, Cheney RT.

Genes Chromosomes Cancer. 2005 Dec;44(4):373-83.

PMID:
16080198
30.

Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.

Dressler LG, Berry DA, Broadwater G, Cowan D, Cox K, Griffin S, Miller A, Tse J, Novotny D, Persons DL, Barcos M, Henderson IC, Liu ET, Thor A, Budman D, Muss H, Norton L, Hayes DF.

J Clin Oncol. 2005 Jul 1;23(19):4287-97.

PMID:
15994142
31.

Hepato- and neurotoxicity induced by thioacetamide: protective effects of melatonin and dimethylsulfoxide.

Túnez I, Muñoz MC, Villavicencio MA, Medina FJ, de Prado EP, Espejo I, Barcos M, Salcedo M, Feijóo M, Montilla P.

Pharmacol Res. 2005 Sep;52(3):223-8.

PMID:
15896975
32.

Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-gamma, and eradicate tumor cells.

Broderick L, Yokota SJ, Reineke J, Mathiowitz E, Stewart CC, Barcos M, Kelleher RJ Jr, Bankert RB.

J Immunol. 2005 Jan 15;174(2):898-906.

33.

Protective effect of Montilla-Moriles appellation red wine on oxidative stress induced by streptozotocin in the rat.

Montilla P, Barcos M, Muñoz MC, Muñoz-Castañeda JR, Bujalance I, Túnez I.

J Nutr Biochem. 2004 Nov;15(11):688-93.

PMID:
15590273
34.

Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology.

Kansal R, Sait SN, Block AW, Ward PM, Kelly FL, Cheney RT, Czuczman M, Brecher ML, Barcos M.

Mod Pathol. 2005 Feb;18(2):235-43.

35.
36.

Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients.

Kansal R, Deeb G, Barcos M, Wetzler M, Brecher ML, Block AW, Stewart CC.

Am J Clin Pathol. 2004 Apr;121(4):512-25.

PMID:
15080303
37.

Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.

Rizzieri DA, Johnson JL, Niedzwiecki D, Lee EJ, Vardiman JW, Powell BL, Barcos M, Bloomfield CD, Schiffer CA, Peterson BA, Canellos GP, Larson RA.

Cancer. 2004 Apr 1;100(7):1438-48.

38.

Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome.

Iyer RV, Sait SN, Matsui S, Block AW, Barcos M, Slack JL, Wetzler M, Baer MR.

Cancer Genet Cytogenet. 2004 Jan 1;148(1):29-34.

PMID:
14697638
39.

Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.

Kampalath B, Barcos MP, Stewart C.

Am J Clin Pathol. 2003 Jun;119(6):824-32.

PMID:
12817430
40.

HLA-DR antigen-negative acute myeloid leukemia.

Wetzler M, McElwain BK, Stewart CC, Blumenson L, Mortazavi A, Ford LA, Slack JL, Barcos M, Ferrone S, Baer MR.

Leukemia. 2003 Apr;17(4):707-15.

PMID:
12682628
41.

Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.

Peterson BA, Petroni GR, Frizzera G, Barcos M, Bloomfield CD, Nissen NI, Hurd DD, Henderson ES, Sartiano GP, Johnson JL, Holland JF, Gottlieb AJ.

J Clin Oncol. 2003 Jan 1;21(1):5-15.

PMID:
12506163
42.

Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes.

Paniagua JA, López-Miranda J, Escribano A, Berral FJ, Marín C, Bravo D, Paz-Rojas E, Gómez P, Barcos M, Moreno JA, Pérez-Jiménez F.

Diabetes. 2002 Aug;51(8):2596-603.

43.

High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.

Lichtman SM, Petroni G, Schilsky RL, Johnson JL, Perri RT, Niedzwiecki D, Sklar J, Barcos M, Peterson BA.

Leuk Lymphoma. 2001 Nov-Dec;42(6):1255-64.

PMID:
11911406
44.

Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia.

Bunworasate U, Arnouk H, Minderman H, O'Loughlin KL, Sait SN, Barcos M, Stewart CC, Baer MR.

Blood. 2001 Dec 1;98(12):3492-4.

PMID:
11719396
45.

Acute myeloid leukemia in the setting of low dose weekly methotrexate therapy for rheumatoid arthritis.

Kolte B, Baer AN, Sait SN, O'Loughlin KL, Stewart CC, Barcos M, Wetzler M, Baer MR.

Leuk Lymphoma. 2001 Jul;42(3):371-8.

PMID:
11699401
46.

Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.

Lee EJ, Petroni GR, Schiffer CA, Freter CE, Johnson JL, Barcos M, Frizzera G, Bloomfield CD, Peterson BA.

J Clin Oncol. 2001 Oct 15;19(20):4014-22. Review.

PMID:
11600602
47.

Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856.

Lester EP, Petroni GR, Barcos M, Johnson JL, Millard FE, Cooper MR, Omura GA, Frei E 3rd, Peterson BA.

Cancer Invest. 2001;19(5):447-58.

PMID:
11458812
48.

Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia.

Xia Z, Sait SN, Baer MR, Barcos M, Donohue KA, Lawrence D, Ford LA, Block AM, Baumann H, Wetzler M.

Leuk Res. 2001 Jun;25(6):473-82.

PMID:
11337019
50.

HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer.

Berry DA, Muss HB, Thor AD, Dressler L, Liu ET, Broadwater G, Budman DR, Henderson IC, Barcos M, Hayes D, Norton L.

J Clin Oncol. 2000 Oct 15;18(20):3471-9.

PMID:
11032587

Supplemental Content

Loading ...
Support Center